Hospira 2Q Revenues: $869.4 million (+29.5) 2Q Earnings: $30.7 million (-43%) YTD Revenues: $1.7 billion (+24%) YTD Earnings: $1.3 million (-99%) Comments: Pharmaceutical contract manufacturing revenues were $36.9 million in the quarter, down 26%, and $78 million YTD, down 23%. 2Q and YTD results include Mayne Pharma integration charges, and charges related to Hospira’s manufacturing initiatives. R&D expenses were $52.5 million, up 35% in the quarter and $96 million...